Leukaemia and L...
Posted by

House of Commons debate on improving cancer outcomes

Leukaemia and L...
Posted by
10 Feb 2015

Last Thursday the Chair of the All Party Parliamentary Group on Cancer (APPG), John Baron MP, led a backbench business debate in the House of Commons on improving cancer outcomes.

There are currently over 2 million people living with, or having survived, cancer in the UK, and last week new analysis from Cancer Research forecast that one in two of us are likely to experience cancer in our lifetime (if current lifestyle factors are not adjusted). Given this, and with 85 days to go to the election, it is more important than ever that improving cancer outcomes is seen as a priority for the next Government.

In leading the debate, John Baron MP identified a number of areas which need to be improved, including early diagnosis and survival rates; inequality in outcomes for older people; and the ability of charities to access data. He also spoke about patient experience and the need for the NHS to deliver good outcomes for patients at every stage of the cancer pathway - something Leukaemia & Lymphoma Research believe is an integral part of how we deliver cancer care. 

Responding to the debate on behalf of the Government, Jane Ellison MP highlighted the importance of NHS England’s independent cancer taskforce in developing a five year plan to improve cancer outcomes. We welcome the inclusion of the views of the wider cancer community to the taskforce, and will be actively contributing to the development of the strategy to ensure the needs of blood cancer patients are represented.

Significant progress has been made in research, prevention, diagnosis and treatment over the past ten years, but it is clear that further progress is needed to improve outcomes for people affected by cancer today, and in the future. It is also essential that a constructive dialogue begins between all parties to get a long term and sustainable system in place that ensures patients can access the treatments they need.

That is why at Leukaemia & Lymphoma Research we are supporting the ‘Cancer: 2million reasons’ campaign, which calls on all political parties to commit to ensuring patients have the best possible outcomes, in line with – and eventually beyond – the best countries in Europe.

To learn more about the campaign click here.

The full text of the debate is available here.

Comments

10.02.2015

Fantastic blog, Lucy - it's so reassuring as a former patient to know that the charity are looking out for the interests of blood cancer patients in parliament. Keep up the good work!